 | • レポートコード：MRC2012B0947 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、膵臓がん治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。膵臓がん治療薬の種類別市場規模（膵臓がん用承認薬、アブラキサン（パクリタキセルアルブミン安定化ナノ粒子製剤）、アフィニトール（エベロリムス）、塩酸エルロチニブ、エベロリムス、5-FU（フルオロウラシル注射）、フルオロウラシル注射、塩酸ゲムシタビン、その他）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Eli Lilly and Company、Teva Pharmaceutical Industries、Novartis、Celgene、Merck、Roche、PharmaCyte Biotech、Amgen、Clovis Oncology、Pfizer、 ・地域別グローバル市場分析 2015年-2020年 ・膵臓がん治療薬の北米市場（アメリカ、カナダ、メキシコ） ・膵臓がん治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・膵臓がん治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・膵臓がん治療薬の南米市場（ブラジル、アルゼンチン） ・膵臓がん治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：膵臓がん用承認薬、アブラキサン（パクリタキセルアルブミン安定化ナノ粒子製剤）、アフィニトール（エベロリムス）、塩酸エルロチニブ、エベロリムス、5-FU（フルオロウラシル注射）、フルオロウラシル注射、塩酸ゲムシタビン、その他 ・用途別分析：病院、クリニック ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Pancreatic Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pancreatic Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pancreatic Cancer Treatment Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pancreatic Cancer Treatment Drugs market has been segmented into:
Drugs Approved for Pancreatic Cancer
Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
Afinitor (Everolimus)
Erlotinib Hydrochloride
Everolimus
5-FU (Fluorouracil Injection)
Fluorouracil Injection
Gemcitabine Hydrochloride
Other
By Application, Pancreatic Cancer Treatment Drugs has been segmented into:
Hospitals
Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pancreatic Cancer Treatment Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Pancreatic Cancer Treatment Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pancreatic Cancer Treatment Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Pancreatic Cancer Treatment Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Pancreatic Cancer Treatment Drugs Market Share Analysis
Pancreatic Cancer Treatment Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pancreatic Cancer Treatment Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pancreatic Cancer Treatment Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Pancreatic Cancer Treatment Drugs are:
Eli Lilly and Company
Teva Pharmaceutical Industries
Novartis
Celgene
Merck
Roche
PharmaCyte Biotech
Amgen
Clovis Oncology
Pfizer
Table of Contents
1 Pancreatic Cancer Treatment Drugs Market Overview
1.1 Product Overview and Scope of Pancreatic Cancer Treatment Drugs
1.2 Classification of Pancreatic Cancer Treatment Drugs by Type
1.2.1 Global Pancreatic Cancer Treatment Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Type in 2019
1.2.3 Drugs Approved for Pancreatic Cancer
1.2.4 Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
1.2.5 Afinitor (Everolimus)
1.2.6 Erlotinib Hydrochloride
1.2.7 Everolimus
1.2.8 5-FU (Fluorouracil Injection)
1.2.9 Fluorouracil Injection
1.2.10 Gemcitabine Hydrochloride
1.2.11 Other
1.3 Global Pancreatic Cancer Treatment Drugs Market by Application
1.3.1 Overview: Global Pancreatic Cancer Treatment Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Pancreatic Cancer Treatment Drugs Market by Regions
1.4.1 Global Pancreatic Cancer Treatment Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pancreatic Cancer Treatment Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pancreatic Cancer Treatment Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pancreatic Cancer Treatment Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pancreatic Cancer Treatment Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pancreatic Cancer Treatment Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pancreatic Cancer Treatment Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eli Lilly and Company
2.1.1 Eli Lilly and Company Details
2.1.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly and Company SWOT Analysis
2.1.4 Eli Lilly and Company Product and Services
2.1.5 Eli Lilly and Company Pancreatic Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Teva Pharmaceutical Industries
2.2.1 Teva Pharmaceutical Industries Details
2.2.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Teva Pharmaceutical Industries SWOT Analysis
2.2.4 Teva Pharmaceutical Industries Product and Services
2.2.5 Teva Pharmaceutical Industries Pancreatic Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Pancreatic Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Celgene
2.4.1 Celgene Details
2.4.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Celgene SWOT Analysis
2.4.4 Celgene Product and Services
2.4.5 Celgene Pancreatic Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Pancreatic Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Pancreatic Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 PharmaCyte Biotech
2.7.1 PharmaCyte Biotech Details
2.7.2 PharmaCyte Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 PharmaCyte Biotech SWOT Analysis
2.7.4 PharmaCyte Biotech Product and Services
2.7.5 PharmaCyte Biotech Pancreatic Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Pancreatic Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Clovis Oncology
2.9.1 Clovis Oncology Details
2.9.2 Clovis Oncology Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Clovis Oncology SWOT Analysis
2.9.4 Clovis Oncology Product and Services
2.9.5 Clovis Oncology Pancreatic Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pfizer SWOT Analysis
2.10.4 Pfizer Product and Services
2.10.5 Pfizer Pancreatic Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pancreatic Cancer Treatment Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pancreatic Cancer Treatment Drugs Players Market Share
3.2.2 Top 10 Pancreatic Cancer Treatment Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pancreatic Cancer Treatment Drugs Revenue and Market Share by Regions
4.2 North America Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
5 North America Pancreatic Cancer Treatment Drugs Revenue by Countries
5.1 North America Pancreatic Cancer Treatment Drugs Revenue by Countries (2015-2020)
5.2 USA Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
6 Europe Pancreatic Cancer Treatment Drugs Revenue by Countries
6.1 Europe Pancreatic Cancer Treatment Drugs Revenue by Countries (2015-2020)
6.2 Germany Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
6.4 France Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pancreatic Cancer Treatment Drugs Revenue by Countries
7.1 Asia-Pacific Pancreatic Cancer Treatment Drugs Revenue by Countries (2015-2020)
7.2 China Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
7.5 India Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
8 South America Pancreatic Cancer Treatment Drugs Revenue by Countries
8.1 South America Pancreatic Cancer Treatment Drugs Revenue by Countries (2015-2020)
8.2 Brazil Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pancreatic Cancer Treatment Drugs by Countries
9.1 Middle East & Africa Pancreatic Cancer Treatment Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pancreatic Cancer Treatment Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Pancreatic Cancer Treatment Drugs Market Forecast by Type (2019-2024)
10.3 Drugs Approved for Pancreatic Cancer Revenue Growth Rate (2015-2025)
10.4 Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation) Revenue Growth Rate (2015-2025)
10.5 Afinitor (Everolimus) Revenue Growth Rate (2015-2025)
10.6 Erlotinib Hydrochloride Revenue Growth Rate (2015-2025)
10.7 Everolimus Revenue Growth Rate (2015-2025)
10.8 5-FU (Fluorouracil Injection) Revenue Growth Rate (2015-2025)
10.9 Fluorouracil Injection Revenue Growth Rate (2015-2025)
10.10 Gemcitabine Hydrochloride Revenue Growth Rate (2015-2025)
10.11 Other Revenue Growth Rate (2015-2025)
11 Global Pancreatic Cancer Treatment Drugs Market Segment by Application
11.1 Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Application (2015-2020)
11.2 Pancreatic Cancer Treatment Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
12 Global Pancreatic Cancer Treatment Drugs Market Size Forecast (2021-2025)
12.1 Global Pancreatic Cancer Treatment Drugs Market Size Forecast (2021-2025)
12.2 Global Pancreatic Cancer Treatment Drugs Market Forecast by Regions (2021-2025)
12.3 North America Pancreatic Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Pancreatic Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pancreatic Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
12.6 South America Pancreatic Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pancreatic Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Pancreatic Cancer Treatment Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pancreatic Cancer Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pancreatic Cancer Treatment Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pancreatic Cancer Treatment Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eli Lilly and Company Corporate Information, Location and Competitors
Table 6. Eli Lilly and Company Pancreatic Cancer Treatment Drugs Major Business
Table 7. Eli Lilly and Company Pancreatic Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Eli Lilly and Company SWOT Analysis
Table 9. Eli Lilly and Company Pancreatic Cancer Treatment Drugs Product and Solutions
Table 10. Eli Lilly and Company Pancreatic Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Teva Pharmaceutical Industries Corporate Information, Location and Competitors
Table 12. Teva Pharmaceutical Industries Pancreatic Cancer Treatment Drugs Major Business
Table 13. Teva Pharmaceutical Industries Pancreatic Cancer Treatment Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Teva Pharmaceutical Industries SWOT Analysis
Table 15. Teva Pharmaceutical Industries Pancreatic Cancer Treatment Drugs Product and Solutions
Table 16. Teva Pharmaceutical Industries Pancreatic Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis Corporate Information, Location and Competitors
Table 18. Novartis Pancreatic Cancer Treatment Drugs Major Business
Table 19. Novartis Pancreatic Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Novartis SWOT Analysis
Table 21. Novartis Pancreatic Cancer Treatment Drugs Product and Solutions
Table 22. Novartis Pancreatic Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Celgene Corporate Information, Location and Competitors
Table 24. Celgene Pancreatic Cancer Treatment Drugs Major Business
Table 25. Celgene Pancreatic Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Celgene SWOT Analysis
Table 27. Celgene Pancreatic Cancer Treatment Drugs Product and Solutions
Table 28. Celgene Pancreatic Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Corporate Information, Location and Competitors
Table 30. Merck Pancreatic Cancer Treatment Drugs Major Business
Table 31. Merck Pancreatic Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Merck SWOT Analysis
Table 33. Merck Pancreatic Cancer Treatment Drugs Product and Solutions
Table 34. Merck Pancreatic Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Roche Corporate Information, Location and Competitors
Table 36. Roche Pancreatic Cancer Treatment Drugs Major Business
Table 37. Roche Pancreatic Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Roche SWOT Analysis
Table 39. Roche Pancreatic Cancer Treatment Drugs Product and Solutions
Table 40. Roche Pancreatic Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. PharmaCyte Biotech Corporate Information, Location and Competitors
Table 42. PharmaCyte Biotech Pancreatic Cancer Treatment Drugs Major Business
Table 43. PharmaCyte Biotech Pancreatic Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 44. PharmaCyte Biotech SWOT Analysis
Table 45. PharmaCyte Biotech Pancreatic Cancer Treatment Drugs Product and Solutions
Table 46. PharmaCyte Biotech Pancreatic Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Amgen Corporate Information, Location and Competitors
Table 48. Amgen Pancreatic Cancer Treatment Drugs Major Business
Table 49. Amgen Pancreatic Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Amgen SWOT Analysis
Table 51. Amgen Pancreatic Cancer Treatment Drugs Product and Solutions
Table 52. Amgen Pancreatic Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Clovis Oncology Corporate Information, Location and Competitors
Table 54. Clovis Oncology Pancreatic Cancer Treatment Drugs Major Business
Table 55. Clovis Oncology Pancreatic Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Clovis Oncology SWOT Analysis
Table 57. Clovis Oncology Pancreatic Cancer Treatment Drugs Product and Solutions
Table 58. Clovis Oncology Pancreatic Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Pfizer Corporate Information, Location and Competitors
Table 60. Pfizer Pancreatic Cancer Treatment Drugs Major Business
Table 61. Pfizer Pancreatic Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Pfizer SWOT Analysis
Table 63. Pfizer Pancreatic Cancer Treatment Drugs Product and Solutions
Table 64. Pfizer Pancreatic Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Pancreatic Cancer Treatment Drugs Revenue (Million USD) by Players (2015-2020)
Table 66. Global Pancreatic Cancer Treatment Drugs Revenue Share by Players (2015-2020)
Table 67. Global Pancreatic Cancer Treatment Drugs Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Regions (2015-2020)
Table 69. North America Pancreatic Cancer Treatment Drugs Revenue by Countries (2015-2020)
Table 70. North America Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Table 71. Europe Pancreatic Cancer Treatment Drugs Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Pancreatic Cancer Treatment Drugs Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Pancreatic Cancer Treatment Drugs Revenue by Countries (2015-2020)
Table 74. South America Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Pancreatic Cancer Treatment Drugs Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Global Pancreatic Cancer Treatment Drugs Revenue (Million USD) by Type (2015-2020)
Table 78. Global Pancreatic Cancer Treatment Drugs Revenue Share by Type (2015-2020)
Table 79. Global Pancreatic Cancer Treatment Drugs Revenue Forecast by Type (2021-2025)
Table 80. Global Pancreatic Cancer Treatment Drugs Revenue by Application (2015-2020)
Table 81. Global Pancreatic Cancer Treatment Drugs Revenue Share by Application (2015-2020)
Table 82. Global Pancreatic Cancer Treatment Drugs Revenue Forecast by Application (2021-2025)
Table 83. Global Pancreatic Cancer Treatment Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pancreatic Cancer Treatment Drugs Picture
Figure 2. Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Type in 2019
Figure 3. Drugs Approved for Pancreatic Cancer Picture
Figure 4. Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation) Picture
Figure 5. Afinitor (Everolimus) Picture
Figure 6. Erlotinib Hydrochloride Picture
Figure 7. Everolimus Picture
Figure 8. 5-FU (Fluorouracil Injection) Picture
Figure 9. Fluorouracil Injection Picture
Figure 10. Gemcitabine Hydrochloride Picture
Figure 11. Other Picture
Figure 12. Pancreatic Cancer Treatment Drugs Revenue Market Share by Application in 2019
Figure 13. Hospitals Picture
Figure 14. Clinics Picture
Figure 15. Global Pancreatic Cancer Treatment Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Pancreatic Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Pancreatic Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Pancreatic Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Pancreatic Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Pancreatic Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Pancreatic Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Pancreatic Cancer Treatment Drugs Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Pancreatic Cancer Treatment Drugs Revenue Market Share in 2019
Figure 24. Global Top 10 Players Pancreatic Cancer Treatment Drugs Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Pancreatic Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Regions (2015-2020)
Figure 28. Global Pancreatic Cancer Treatment Drugs Revenue Market Share by Regions in 2018
Figure 29. North America Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Europe Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 32. South America Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 34. North America Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 35. North America Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries in 2019
Figure 36. USA Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Canada Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Europe Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries in 2019
Figure 41. Germany Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 42. UK Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 43. France Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Russia Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Italy Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries in 2019
Figure 48. China Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Japan Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Korea Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 51. India Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 53. South America Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. South America Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries in 2019
Figure 55. Brazil Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Pancreatic Cancer Treatment Drugs Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 60. UAE Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Pancreatic Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 63. Global Pancreatic Cancer Treatment Drugs Revenue Share by Type (2015-2020)
Figure 64. Global Pancreatic Cancer Treatment Drugs Revenue Share by Type in 2019
Figure 65. Global Pancreatic Cancer Treatment Drugs Market Share Forecast by Type (2021-2025)
Figure 66. Global Drugs Approved for Pancreatic Cancer Revenue Growth Rate (2015-2020)
Figure 67. Global Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation) Revenue Growth Rate (2015-2020)
Figure 68. Global Afinitor (Everolimus) Revenue Growth Rate (2015-2020)
Figure 69. Global Erlotinib Hydrochloride Revenue Growth Rate (2015-2020)
Figure 70. Global Everolimus Revenue Growth Rate (2015-2020)
Figure 71. Global 5-FU (Fluorouracil Injection) Revenue Growth Rate (2015-2020)
Figure 72. Global Fluorouracil Injection Revenue Growth Rate (2015-2020)
Figure 73. Global Gemcitabine Hydrochloride Revenue Growth Rate (2015-2020)
Figure 74. Global Other Revenue Growth Rate (2015-2020)
Figure 75. Global Pancreatic Cancer Treatment Drugs Revenue Share by Application (2015-2020)
Figure 76. Global Pancreatic Cancer Treatment Drugs Revenue Share by Application in 2019
Figure 77. Global Pancreatic Cancer Treatment Drugs Market Share Forecast by Application (2021-2025)
Figure 78. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 79. Global Clinics Revenue Growth Rate (2015-2020)
Figure 80. Global Pancreatic Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Pancreatic Cancer Treatment Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Pancreatic Cancer Treatment Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Pancreatic Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
Figure 84. Europe Pancreatic Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Pancreatic Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
Figure 86. South America Pancreatic Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Pancreatic Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
転移性膵臓がん治療の世界市場（～2026年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…- 転移性膵臓がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Metastatic Pancreatic Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…
- 膵臓がん治療の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 膵臓がん治療薬の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 膵臓がん診断の世界市場（～2026年） Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. This report studies the Pancreatic Cancer Diagnostic market, includes Tumor Biomarker Tests, Imaging, Bio…